Able Laboratories, Inc. - Strategic Analysis Review
Able Laboratories, Inc. is engaged in the development and manufacturing of generic pharmaceutical products in tablet, capsule, liquid and suppository dosage forms. The company is b
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Alliant Pharmaceuticals, Inc. - Strategic Analysis Review
Alliant Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on acquiring, developing and commercializing proprietary products for the pediatric and ped
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
AltaRex Medical Corp. - Strategic Analysis Review
This comprehensive SWOT profile of AltaRex Medical Corp. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by Gl
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
ANDRX Corporation - Strategic Analysis Review
Andrx Corporation is a pharmaceutical company engaged in developing and commercializing generic versions of primarily controlled-release pharmaceutical products as well as oral con
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
ARIUS Research Inc. - Strategic Analysis Review
ARIUS Research, Inc. is a biotechnology company discovering and developing the antibody therapeutics to treat cancer and other diseases
This comprehensive SWOT profile of ARIUS Re
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Astra Merck Inc. - Strategic Analysis Review
This comprehensive SWOT profile of Astra Merck Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalD
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Atrix Laboratories, Inc. - Strategic Analysis Review
Atrix Laboratories, Inc. a Fort Collins, Colorado based biopharmaceutical company focused on advanced drug delivery. The company currently developing a diverse portfolio of product
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
AXYS Pharmaceuticals, Inc - Strategic Analysis Review
This comprehensive SWOT profile of AXYS Pharmaceuticals, Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled b
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Beijing Centergate Technologies (Holding) Co., Ltd. - Strategic Analysis Review
This comprehensive SWOT profile of Beijing Centergate Technologies (Holding) Co., Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The p
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Bone Care International, Inc. - Strategic Analysis Review
Bone Care International, Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of therapeutic products to treat the unmet medical needs of pa
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Bradley Pharmaceuticals, Inc. - Strategic Analysis Review
Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company. It acquires, develops, and markets prescription and over the counter products in therapeutic markets, including
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Calzada Limited - Strategic Analysis Review
This comprehensive SWOT profile of Calzada Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalDa
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Cambridge Neuroscience - Strategic Analysis Review
This comprehensive SWOT profile of Cambridge Neuroscience provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by G
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
CeNeS Pharmaceuticals plc - Strategic Analysis Review
CeNeS Pharmaceuticals plc is a biopharmaceutical company. The company is engaged in the discovery and development of novel drug products for the treatment of disorders related to c
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
CIPAN - Cia Ind Prom de Ant SA - Strategic Analysis Review
This comprehensive SWOT profile of CIPAN - Cia Ind Prom de Ant SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compi
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
COLLTECH AUSTRALIA LIMITED - Strategic Analysis Review
This comprehensive SWOT profile of COLLTECH AUSTRALIA LIMITED provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
COR Therapeutics, Inc. - Strategic Analysis Review
This comprehensive SWOT profile of COR Therapeutics, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by G
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Corautus Genetics Inc. - Strategic Analysis Review
Corautus Genetics Inc. was acquired by VIA Pharmaceuticals, Inc. in a reverse merger transaction. It does not have significant operations. Previously, the company was focused on t
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Corgentech Inc. - Strategic Analysis Review
This comprehensive SWOT profile of Corgentech Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalDa
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Corixa Corporation - Strategic Analysis Review
Corixa Corporation is a biopharmaceutical company engaged in developing vaccine adjuvants and immunology based products that manage human diseases. The company primarily focuses on
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Coserics, LLC - Strategic Analysis Review
This comprehensive SWOT profile of Coserics, LLC provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
CoTherix, Inc. - Strategic Analysis Review
CoTherix, Inc. is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the potential treatment of cardiovascular disease
This
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Crucell Switzerland AG - Strategic Analysis Review
Crucell Switzerland AG (Crucell) is a private biopharmaceutical company engaged in producing vaccines and antibodies. The company offers drugs to diseases related to various fields
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Cryosite Limited - Financial and Strategic Analysis Review
Cryosite Limited is a pharmaceutical company founded to offer specialised outsourced logistics services to it's clients services includes sample management, supply management and
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
Cytran Inc. - Strategic Analysis Review
This comprehensive SWOT profile of Cytran Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData t
Mercado: Fármacos / Medicamentos
|
2010 |
125,00$ |
